Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Short-term Investments (2019 - 2023)

Marimed (MRMD) has disclosed Short-term Investments for 10 consecutive years, with $88000.0 as the latest value for Q4 2023.

  • On a quarterly basis, Short-term Investments fell 28.46% to $88000.0 in Q4 2023 year-over-year; TTM through Dec 2023 was $88000.0, a 28.46% decrease, with the full-year FY2023 number at $88000.0, down 28.46% from a year prior.
  • Short-term Investments was $88000.0 for Q4 2023 at Marimed, down from $161000.0 in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $1.4 million in Q4 2019 to a low of $88000.0 in Q4 2023.
  • A 5-year average of $655710.1 and a median of $643571.0 in 2020 define the central range for Short-term Investments.
  • Peak YoY movement for Short-term Investments: skyrocketed 72.15% in 2021, then crashed 91.7% in 2023.
  • Marimed's Short-term Investments stood at $1.4 million in 2019, then dropped by 6.35% to $1.4 million in 2020, then crashed by 81.51% to $251000.0 in 2021, then plummeted by 51.0% to $123000.0 in 2022, then decreased by 28.46% to $88000.0 in 2023.
  • Per Business Quant, the three most recent readings for MRMD's Short-term Investments are $88000.0 (Q4 2023), $161000.0 (Q3 2023), and $102000.0 (Q2 2023).